US Patent Issued to The Regents of the University of California on April 29 for "Gene therapy for haploinsufficiency" (California Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,496, issued on April 29, was assigned to The Regents of the University of California (Oakland, Calif.).

"Gene therapy for haploinsufficiency" was invented by Nadav Ahituv (San Francisco) and Navneet Matharu (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and compositions are provided for activating transcription in a mammalian cell."

The patent was filed on Oct. 11, 2022, under Application No. 17/963,901.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12285496...